| Entry |
|
|---|
| Name |
Ciglitazone (USAN/INN) |
|---|
| Formula |
C18H23NO3S
|
|---|
| Exact mass |
333.1399
|
|---|
| Mol weight |
333.45
|
|---|
| Structure |
|
|---|
| Class |
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01683 Thiazolidinedione type PPAR agonist
DG02044 Hypoglycemic agent
DG01683 Thiazolidinedione type PPAR agonist
|
|---|
| Efficacy |
Antidiabetic, Peroxisome proliferator-activated receptor (PPAR) gamma agonist |
|---|
| Comment |
Thiazolidinedione derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07222 | Peroxisome proliferator-activated receptor (PPAR) agonists |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01683 Thiazolidinedione type PPAR agonist
D03493 Ciglitazone
DG02044 Hypoglycemic agent
DG01683 Thiazolidinedione type PPAR agonist
D03493 Ciglitazone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C3 (PPARG)
D03493 Ciglitazone (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 23
1 C1y C 31.2900 -19.3900
2 C1b C 30.0300 -18.6900
3 C8y C 28.8400 -19.3900
4 C8x C 27.6500 -18.6900
5 C8x C 28.8400 -20.7900
6 C8x C 26.3900 -19.3900
7 C8x C 27.6500 -21.4900
8 C8y C 26.3900 -20.7900
9 O2a O 25.2000 -21.4900
10 C1b C 23.9400 -20.7900
11 C1z C 22.7500 -21.4900
12 C1x C 21.5600 -20.7900
13 C1x C 20.3700 -21.4900
14 C1x C 20.3700 -22.8900
15 C1x C 21.5600 -23.5900
16 C1x C 22.7500 -22.8900
17 C1a C 22.7500 -20.0900
18 C5x C 31.2840 -20.7900
19 N1x N 32.6137 -21.2283
20 C5x C 33.4414 -20.0992
21 S2x S 32.6233 -18.9631
22 O5x O 34.8599 -20.1053
23 O5x O 30.1519 -21.6052
BOND 25
1 1 2 1
2 2 3 1
3 3 4 2
4 3 5 1
5 4 6 1
6 5 7 2
7 6 8 2
8 8 9 1
9 9 10 1
10 10 11 1
11 7 8 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 11 16 1
18 11 17 1
19 1 18 1
20 18 19 1
21 19 20 1
22 20 21 1
23 1 21 1
24 20 22 2
25 18 23 2
|
|---|
